FDA announces recall of some liquid pharmaceutical products

August 16, 2017

(HealthDay)—The U.S. Food and Drug Administration has announced a recall of numerous liquid pharmaceutical products because of possible bacterial contamination that could cause severe infections in vulnerable patients.

The drugs and dietary supplements, made by PharmaTech LLC in Davie, Fla., include liquid stool softeners, liquid vitamin D drops and liquid multivitamins marketed for infants and children, the agency said in a news release.

Reports of the discovery of Burkholderia cepacia bacteria in both Diocto Liquid and Diocto Syrup prompted the voluntary recall by three companies that label PharmaTech products, the FDA said. The three companies are Rugby Laboratories, Major Pharmaceuticals and Leader Brands.

"B. cepacia poses a serious threat to vulnerable patients, including infants and young children who still have developing immune systems," FDA Commissioner Dr. Scott Gottlieb said in a statement.

"These products were distributed nationwide to retailers, , pharmacies and sold online—making it important that parents, patients and be made aware of the potential risk and immediately stop using these products," Gottlieb added.

The bacteria pose the greatest danger to hospitalized patients, and people with health problems such as and chronic lung diseases, according to the U.S. Centers for Disease Control and Prevention.

Signs of infection can range from no symptoms at all to serious respiratory infections, the CDC said. The bacteria can spread from person to person by direct contact and is often resistant to common antibiotics.

The FDA advises patients and physicians to stop using these products immediately. Consumers with questions can contact Rugby Laboratories/Major Pharmaceuticals at 800-645-2158, or Leader at 800-200-6313.

Explore further: Infectious outbreak in critically ill children leads to recall of contaminated medication

More information: SOURCE: U.S. Food and Drug Administration, news release, Aug. 11, 2017

Here is the FDA's complete list of the recalled products.

Related Stories

Infectious outbreak in critically ill children leads to recall of contaminated medication

February 9, 2017
Infection prevention and control experts at Texas Children's Hospital halted a 24-patient outbreak of Burkholderia cepacia in critically ill children after identifying docusate, a liquid stool softener, as the underlying ...

FDA will target e-cigs in health campaign for youth

August 8, 2017
(HealthDay)—The U.S. Food and Drug Administration will now include electronic cigarettes in a public health education campaign to discourage American youth from using tobacco and nicotine products.

Antibiotics are not always the answer

July 7, 2017
The discovery of penicillin in 1928 was heralded as a medical miracle. As one of the first antibiotics, it could cure patients of potentially deadly bacterial illnesses, such as scarlet fever, typhoid and pneumonia.

FDA: Ameridose issues voluntary recall of all products

November 2, 2012
(HealthDay)—Ameridose, a Massachusetts-based manufacturer of sterile injectable products and oral syringes, is undergoing a voluntary recall of all unexpired products in circulation, according to an Oct. 31 news release ...

Recommended for you

Helping preterm infants grow bigger kidneys would prevent kidney disease later in life

May 21, 2018
Nephrons are the microscopic blood-filtering units inside our kidneys that convert waste products into urine, regulate our electrolyte levels and our blood pressure.

Kidney docs worry over no dialysis for undocumented immigrants

May 21, 2018
(HealthDay)—Undocumented immigrants in the United States are often denied treatment for kidney failure until they have a life-threatening emergency. Now a new study finds that the doctors and nurses who treat them are frustrated ...

Clues found to early lung transplant failure

May 21, 2018
Among organ transplant patients, those receiving new lungs face a higher rate of organ failure and death compared with people undergoing heart, kidney and liver transplants. One of the culprits is inflammation that damages ...

How to ethically conduct clinical research during public health emergencies

May 21, 2018
Following the 2014-2015 Ebola outbreak in West Africa, the U.S. National Academy of Sciences, Engineering and Medicine established a committee to assess the clinical trials conducted in Guinea, Sierra Leone and Liberia. In ...

Anxious women may want to keep an eye on their bone health

May 18, 2018
(HealthDay)—As if older women didn't already worry enough about their bone health, new research suggests that anxiety may up their risk for fractures.

FDA approves first drug aimed at preventing migraines

May 18, 2018
(HealthDay)—The millions of Americans who suffer from migraine may have a new source of hope—the first drug aimed at preventing the headaches gained U.S. Food and Drug Administration approval on Thursday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.